EP2303021
Efnasambönd til meðferðar á krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.6.2009EP published:
19.12.2018EP application number:
09835407.9
EP translation filed:
18.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
15.6.2029Expiry date:
15.6.2021
Title:
COMPOUNDS FOR THE TREATMENT OF CANCER
Timeline
Today
16.6.2009EP application
19.12.2018EP Publication
18.3.2019Translation submitted
15.4.2019Registration published
15.6.2021Expires
Owner
Name:
University of Tennessee Research FoundationAddress:
211 Conference Center Building 600 Henley Street, 37996, Knoxville, TN, US
Name:
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATIONAddress:
1216 Kinnear Road, 43212-1154, Columbus, OH, US
Inventor
Name:
MILLER, Duane, D.Address:
ColliervilleTN, US
Name:
LI, WeiAddress:
GermantownTN, US
Name:
WANG, ZhaoAddress:
ExtonPA, US
Name:
LU, YanAddress:
Collierville, TN,, US
Name:
CHEN, JianjunAddress:
1838, Guangzhou Avenue NorthGuangzhou 510515, CN
Name:
DALTON, James, T.Address:
Ann Arbor MI, US
Name:
LI, Chien-MingAddress:
Cupertino CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
61875 PDate:
16.6.2008Country:
US
Classification
Categories:
A01N 43/64, A61K 31/41, C07D 233/02, C07D 233/22, C07D 233/54, C07D 263/06, C07D 263/14, C07D 277/04, C07D 401/04, C07D 401/06, C07D 413/04, C07D 413/06, C07D 417/06, A61K 31/4178, A61K 31/422, A61K 31/427, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 27.5.2019
Expires: 15.6.2020
Payer: Tego ehf.
Number: 12
Paid: 5.5.2020
Expires: 15.6.2021
Payer: Árnason Faktor ehf.